Nymox Pharmaceutical Corporation (Nasdaq: NYMX) is pleased to announce that the first patient has been enrolled in the Company's Study ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE